Benitec Biopharma

Benitec Biopharma

Biotechnology, 3940 Trust Way, Hayward, California, 94545, United States, 11-50 Employees

benitec.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +61**********

Who is BENITEC BIOPHARMA

Benitec is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference (RNAi) with gene therapy with a goal of providing sustained, lon...

Read More

map
  • 3940 Trust Way, Hayward, California, 94545, United States Headquarters: 3940 Trust Way, Hayward, California, 94545, United States
  • 2001 Date Founded: 2001
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BENITEC BIOPHARMA

Benitec Biopharma Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Benitec Biopharma

Answer: Benitec Biopharma's headquarters are located at 3940 Trust Way, Hayward, California, 94545, United States

Answer: Benitec Biopharma's phone number is +61**********

Answer: Benitec Biopharma's official website is https://benitec.com

Answer: Benitec Biopharma's revenue is $10 Million to $25 Million

Answer: Benitec Biopharma's SIC: 8731

Answer: Benitec Biopharma's NAICS: 541714

Answer: Benitec Biopharma has 11-50 employees

Answer: Benitec Biopharma is in Biotechnology

Answer: Benitec Biopharma contact info: Phone number: +61********** Website: https://benitec.com

Answer: Benitec is a biotechnology company developing a proprietary therapeutic technology platform that combines RNA interference (RNAi) with gene therapy with a goal of providing sustained, long-lasting silencing of disease-causing genes from a single administration. Benitec is using its technology, called DNA-directed RNA interference (ddRNAi) to develop a pipeline of product candidates for the treatment of several chronic and life-threatening human diseases , including oculopharyngeal muscular dystrophy (OPMD) and hepatitis B. By combining the specificity and gene silencing effect of RNAi with gene therapy, ddRNAi has the potential to produce long-lasting silencing of disease-causing genes from a single administration, which could minimize the requirement for patients to take regular doses of medicine. Benitecs objective is to become the leader in discovering, developing, clinically validating and commercializing ddRNAi-based therapeutics for a range of human diseases with high unmet clinical need or large patient populations and, as a result, provide a better life for patients with these diseases.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access